Lv5
1140 积分 2023-02-19 加入
Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7
5小时前
待确认
Targeting MET-mediated TKI resistance in EGFR-mutant NSCLC
16天前
已完结
European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
1个月前
已完结
Progress in Disease-Modifying Therapies for Parkinson's Disease
1个月前
已完结
Genetics of Parkinson's Disease: From Causes to Treatment
1个月前
已完结
Disease-Modifying Therapies in Parkinson’s Disease
1个月前
已关闭
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
2个月前
已完结
Efficacy and Safety of Ravulizumab in IgA Nephropathy
3个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
Cancer incidence and mortality in China, 2022
4个月前
已完结
皖公网安备34019202002308
